Sp1209

ENTERIC GLIA: A NEW PLAYER IN ABDOMINAL PAIN

Date
May 9, 2023
Explore related products in the following collection:

Society: AGA

Abdominal pain is one of the most common reasons for doctors visits, and presents in numerous GI diseases. Unfortunately the current treatment options targeting sensory neurons to reduce pain have limited efficacy or unwanted side effects, and this is especially true for visceral pain. Recent evidence strongly suggests that non-neuronal cell populations found in the gut, including epithelial cells, enteric glia, immune cells and gut microbiota, play major roles in visceral pain by directly interacting with sensory neurons that carry pain information. In this session, you will learn about how these 'unusual suspects' (i.e., non-neuronal cell types) are involved in visceral pain processes and and how manipulating their activity reduces hypersensitivity, inflammation, and other GI disease outcomes.

Presenter

Speaker Image for Brian Gulbransen
Michigan State University

Tracks

Related Products

Thumbnail for AGA Novel Mechanisms of Intercellular Communication That Control Gut Motility?
AGA Novel Mechanisms of Intercellular Communication That Control Gut Motility?
This session will focus on intercellular signaling mechanisms between neurons and non-neuronal cells that control gut motor functions…
Thumbnail for EARLY LIFE ADVERSITY DISRUPTS SEXUAL DIMORPHISM OF ENTERIC GLIA
EARLY LIFE ADVERSITY DISRUPTS SEXUAL DIMORPHISM OF ENTERIC GLIA
Electrogastrography (EGG) non-invasively evaluates gastric motility but is widely viewed as lacking clinical utility…
Thumbnail for MONITORING OF CALPROTECTIN IN INFLAMMATORY BOWEL DISEASE USING A SWEAT BASED WEARABLE DEVICE
MONITORING OF CALPROTECTIN IN INFLAMMATORY BOWEL DISEASE USING A SWEAT BASED WEARABLE DEVICE
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
Thumbnail for PLACEHOLDER
PLACEHOLDER
Perturbations in the gut mucosal immune response contributes to IBD. Non-immune cell popopulations including epithelial and stromal cells also play an important role in intestinal inflammation…